All In MedTech

Device Trial Radar · NCT07801105

Hormone-free Antral Retrieval for Viable Embryo Storage & Transfer

A Prospective Adaptive Pilot Study of Serial Unstimulated Oocyte Retrieval and CAPA-IVM (Capacitation In Vitro Maturation) for Euploid Embryo Accumulation in Women With Robust Ovarian Reserve

Last checked: Nov 20, 2026Latest source record: Sep 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

30

Planned (sponsor's estimate)

Start

Sep 2026

Primary completion

Mar 2027

Study completion Mar 2028

Sponsor

Lead sponsor
Kevin DoodyNot on our public-company list
Sponsor type
Industry
Collaborators
Lavima Fertility
First posted
Sep 3, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
Female only, from 18 years, up to 35 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is testing whether eggs can be collected from small follicles without using the usual ovarian stimulation medications. Participants will have up to three egg retrieval procedures. The eggs collected during each retrieval will be matured in the laboratory using the CAPA-IVM (Capacitation In Vitro Maturation) process, fertilized, grown into embryos, and tested to identify chromosomally normal embryos. Embryos from the retrievals may be frozen and accumulated. If a suitable embryo is available, one chromosomally normal embryo may be transferred. The study will also monitor safety, hormone levels, follicle development, embryo development, pregnancy results, and how well participants tolerate the study procedures.

Conditions

  • Infertility

Interventions

  • CAPA-IVM SystemDevice

    The CAPA-IVM System Kit will be used in the laboratory to support collection, handling, capacitation, and maturation of immature cumulus-oocyte complexes retrieved from visible 4-9 mm antral follicles.

  • Serial Unstimulated Transvaginal Oocyte RetrievalProcedure

    Participants will undergo up to three unstimulated transvaginal oocyte retrievals targeting visible 4-9 mm antral follicles, without exogenous gonadotropin stimulation or ovulatory trigger medication.

  • ICSI, Blastocyst Culture, PGT-A, Embryo Vitrification/Accumulation, and Single Euploid Embryo TransferProcedure

    Retrieved oocytes will undergo CAPA-IVM followed by ICSI, blastocyst culture, PGT-A, embryo vitrification/accumulation, and single euploid embryo transfer if a suitable euploid embryo is available.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of euploid embryos per retrievalTime frame: From first egg retrieval to final PGT-A results, approximately 4 weeks.

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • CARE Fertility Texas

    Bedford, Texas · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.